Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy.

Journal of gastroenterology - 1 Jan 2003

Sezaki Hitomi, Arase Yasuji, Tsubota Akihito, Suzuki Yoshiyuki, Kobayashi Masahiro, Saitoh Satoshi, Suzuki Fumitaka, Akuta Norio, Someya Takashi, Ikeda Kenji, Kumada Hiromitsu

Abstract excerpt

Of a total of 2342 patients with type-C chronic hepatitis treated with interferon (IFN) at this hospital, 3 patients developed jaundice during the course of IFN therapy, but all 3 of them exhibited negative conversion of hepatitis C virus (HCV)-RNA following readministration of IFN. All 3 patients were assessed as having "probable autoimmune hepatitis (AIH)" in accordance with the AIH scoring system, indicating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aspartate Aminotransferases

Share to Hepacivirus

Share to Hepatitis, Autoimmune

Share to Hepatitis C, Chronic

Share to Interferon-beta

Share to Jaundice

Source

Identifiers

PMID: 12768394
DOI: 10.1007/s00535-002-1090-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy.PMID 12768394Read ↗

[Extrahepatic manifestations in hepatitis C. Are they overlooked?].Semantic proximity Read ↗

Autoantibodies in chronic liver disease.Semantic proximity Read ↗

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group.Semantic proximity Read ↗

Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels.Semantic proximity Read ↗

Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome.Semantic proximity Read ↗

Serum islet cell autoantibodies during interferon alpha treatment in patients with HCV-genotype 4 chronic hepatitis.Semantic proximity Read ↗

[Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].Semantic proximity Read ↗

Comparisons of peripheral blood and hepatic lymphocyte subpopulations and interferon production in chronic viral hepatitis.Semantic proximity Read ↗

Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis.Semantic proximity Read ↗

[Immunologic diseases and hepatitis C virus].Semantic proximity Read ↗

Cases of interferon-alpha and interferon-beta-induced thyroiditis.Semantic proximity Read ↗

[Interferon therapy for acute hepatitis C; changes in serum markers associated with HCV and clinical effects].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.